184 related articles for article (PubMed ID: 2146977)
1. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
[TBL] [Abstract][Full Text] [Related]
2. Uptake of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, delivered to cultured human fibroblasts by serum proteins. Lack of evidence for perturbation of LDL catabolism.
Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
Biochim Biophys Acta; 1990 Nov; 1055(2):102-6. PubMed ID: 2146974
[TBL] [Abstract][Full Text] [Related]
3. Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes.
Urien S; Claudepierre P; Meyer J; Brandt R; Tillement JP
Biochem Pharmacol; 1992 Nov; 44(9):1891-3. PubMed ID: 1449542
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of Etretinate (Ro 10-9359) and its metabolite (Ro 10-1670).
Ishizaki H; Masuda H; Kaseda H; Kaminaga T; Hirone T
J Dermatol; 1983 Oct; 10(5):421-6. PubMed ID: 6230381
[No Abstract] [Full Text] [Related]
5. High-performance liquid chromatography of Ro 10-9359 (tigason) and its metabolite Ro 10-1670 in human plasma.
Besner JG; Meloche S; Leclaire R; Band P; Mailhot S
J Chromatogr; 1982 Sep; 231(2):467-72. PubMed ID: 6215418
[No Abstract] [Full Text] [Related]
6. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
Berne B; Rollman O; Vahlquist A
Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
Jakobsen P; Larsen FG; Larsen CG
J Chromatogr; 1987 Apr; 415(2):413-8. PubMed ID: 2953748
[No Abstract] [Full Text] [Related]
8. Etretinate: effect of milk intake on absorption.
DiGiovanna JJ; Gross EG; McClean SW; Ruddel ME; Gantt G; Peck GL
J Invest Dermatol; 1984 Jun; 82(6):636-40. PubMed ID: 6233379
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. II. Simultaneous determination of etretinate, acitretin and 13-cis-acitretin in plasma.
Wyss R; Bucheli F
J Chromatogr; 1988 Oct; 431(2):297-307. PubMed ID: 2977389
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
De Leenheer AP; Lambert WE; De Bersaques JP; Kint AH
J Chromatogr; 1990 Feb; 500():637-42. PubMed ID: 2139439
[TBL] [Abstract][Full Text] [Related]
11. Determination of plasma levels of two aromatic retinoic acid analogues with antipsoriatic activity by high-performance liquid chromatography.
Palmskog G
J Chromatogr; 1980 Dec; 221(2):345-51. PubMed ID: 6452462
[TBL] [Abstract][Full Text] [Related]
12. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
Brouwer KR; McNamara PJ
Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
[TBL] [Abstract][Full Text] [Related]
13. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
Löfberg B; Reiners J; Spielmann H; Nau H
Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous microassay for etretinate and its active metabolite, etretin, by reversed-phase high-performance liquid chromatography.
Thongnopnua P; Zimmerman CL
J Chromatogr; 1988 Dec; 433():345-51. PubMed ID: 2976770
[No Abstract] [Full Text] [Related]
15. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
Rollman O; Vahlquist A
Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
[TBL] [Abstract][Full Text] [Related]
16. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.
Ashley JM; Lowe NJ; Borok ME; Alfin-Slater RB
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):76-82. PubMed ID: 2969924
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
McNamara PJ; Blouin RA
J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
[TBL] [Abstract][Full Text] [Related]
18. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
Ledo A; Martín M; Geiger JM; Marrón JM
Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
[TBL] [Abstract][Full Text] [Related]
19. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
Gollnick H; Orfanos CE
Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
Kochhar DM; Penner JD; Minutella LM
Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
